In another interesting study, Liu et al. showed, in a subset of EGFR-positive NSCLC patients, that allele frequency heterogeneity (AFH) defined by ctDNA is associated with poor prognosis and shorter overall survival [50]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.